Status:
UNKNOWN
Establishment and Validation of a Predictive Model for Hemorrhage
Lead Sponsor:
Shenzhen Second People's Hospital
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Brief Summary
Background: Patients with acute ischemic stroke (AIS) are at risk of hemorrhagic transformation (HT) after intravenous thrombolysis. Although there is a risk assessment model for hemorrhagic transform...
Detailed Description
This study has two main parts. The first part is to verify and optimize the clinical application effect of the existing prediction model. The clinical data of the acute ischemic stroke intravenous thr...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old;
- Onset time \<4.5 hours;
- Meet the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018, and have been examined by plain CT/MRI of the head, and hemorrhagic stroke is excluded by head CT;
- AIS patients receiving intravenous thrombolysis.
Exclusion
- The main clinical data is incomplete;
- Patients treated by intraarterial thrombolysis or interventional thrombectomy;
- Patients with transient ischemic attack;
- Those who refuse to participate in this research.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04745052
Start Date
March 1 2021
End Date
July 1 2023
Last Update
February 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China, 518035
2
China
Guandong, Shenzhen, China, 518035